Leg Cramps PM

Product NDC

54973-3093

11-digit product format

549733093

Labeler code

54973

Product ID

54973-3093_2b4a2bff-d93e-6377-e063-6394a90a2e0a

Type

HUMAN OTC DRUG

Nonproprietary name

oyster shell calcium carbonate, crude, causticum, matricaria recutita, cinchona officinalis bark, copper, lycopodium clavatum spore, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, silicon dioxide, and sulfur

Dosage form

TABLET, SOLUBLE

Route

ORAL

Labeler

Hyland's Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2010-01-01

Substance

CAUSTICUM; CINCHONA OFFICINALIS BARK; COPPER; LYCOPODIUM CLAVATUM SPORE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MATRICARIA RECUTITA; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; SULFUR; TOXICODENDRON PUBESCENS LEAF

Active strength

12; 3; 12; 12; 6; 6; 12; 12; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1

Pharmacologic classes

Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

NDC exclude flag

No

Listing certified through

2026-12-31

Current FDA listing

Yes